SurModics

Traded on the St. Petersburg Stock Exchange
Surmodics, Inc. designs and manufactures medical devices. The Company offers coronary stent systems, angioplasty catheters, chronic total occlusion devices, specialty guide wires, and intravascular sensors.
SurModics stock price chart
vol.
change
P/E adj.
Net profit (adj.)
P/B
Book value
P/FCF
FCF
Yield
Growth potential

SurModics balance sheet

Report period2017 2018 2019 2020 2021 2022
End date of the reporting period
Capitalization, $
Capitalization, $
Enterprise Value
Book Value
Shareholders Book Value
Current liabilities
Noncurrent liabilities
Total liabilities
Debt
Cash and cash equivalents
Net debt
Assets
Total ordinary shares
Ordinary share price

SurModics cash flows

Report period2017 2018 2019 2020 2021 2022
End date of the reporting period
Sales
Gross profit
Operation Income
Earnings
Shareholders earnings
Adjusted Earnings
EBITDA
Adjusted EBITDA
Operation Cashflow
Capital expenditure
Free Cash Flow
EPS
Adjusted EPS

SurModics multipliers

Report period2017 2018 2019 2020 2021 2022
P/E
P/E adj.
E/P
E adj./P
P/B
P/S
P/FCF
L/A
Debt-To-Equity
Net Debt/EBITDA
Net Debt/EBITDA adj.
EV/EBITDA
EV/EBITDA adj.

SurModics profitability

Report period2017 2018 2019 2020 2021 2022
ROA
ROE
ROS
Gross margin
EBITDA Margin
Operating margin
SurModics assets
SurModics cash flows

SurModics shares

TickerNameTypeNominal valueISINPrice
SRDX:USSurModics, Inc.Common share-US8688731004$27.66
SurModics news
27.04.2022
SurModics' GAAP loss for 6 months of fiscal year 2022 was $6.895 million, compared to a profit of $7.813 million in the previous year. Revenue decreased 14.3% to $49.109 million from $57.292 million a year earlier.
Source: {source} pictogram surmodics.gcs-web.com
Pictogram next
03.02.2022
The loss of SurModics under GAAP for 3 months of fiscal year 2022 was $2.812 million, up 10.3 times from $0.274 million in the previous year. Revenue increased 3.2% to $23.003 million from $22.297 million a year earlier.
Source: {source} pictogram surmodics.gcs-web.com
Pictogram next
10.11.2021
SurModics' GAAP net income for fiscal year 2021 was $4.237 million, up 3.77 times from $1.123 million in the previous year. Revenue increased 10.8% to $105.136 million from $94.864 million a year earlier.
Source: {source} pictogram surmodics.gcs-web.com
Pictogram next
04.08.2021
SurModics' GAAP net income for 9 months of fiscal year 2021 was $4.526 million, up 11.2% from $4.069 million in the prior year. Revenue increased 12.2% to $81.165 million from $72.321 million a year earlier.
Source: {source} pictogram surmodics.gcs-web.com
Pictogram next
All SurModics news
General information
Company nameSurModics
Tags#medtech
SectorHealth Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Equipment
Business address9924 W 74TH ST EDEN PRAIRIE MN 55344 9525007000
Mailing address9924 WEST 74TH ST EDEN PRAIRIE MN 55344
Websitewww.surmodics.com
Information disclosurewww.sec.gov